Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
$87.58−2.62 (-2.90%)
Close on Nov 13, 2026Market cap $6.88BP/E –Yield –
Abivax market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Abivax's market cap was $7.30B on Nov 11, 2026, against $7.87B a year earlier. Over the last 3 years it ranged from $205.17M to $10.57B, with a median of $899.72M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.30B | -14.2% |
| 2025 | Dec 31, 2025 | $8.50B | +1746.1% |
| 2024 | Dec 31, 2024 | $460.56M | +93.0% |
| 2023 | Dec 29, 2023 | $238.62M | – |
See a number that looks wrong?